£13 million for 22 AI for health research projects
Projects aim to transform health using artificial intelligence (AI) to assist and refine diagnostics and procedures.
Creating the world’s largest longitudinal medical imaging dataset
Public-private partnership announces ambitious project to create the world’s largest longitudinal imaging dataset to assess disease progression.
Constructive Bio to build on synthetic biology breakthroughs
Medical Research Council’s (MRC) Laboratory of Molecular Biology launches a new spinout company, Constructive Bio, which secured $15 million seed investment.
Medical Research Council extends Blue Sky research collaboration with AstraZeneca
The Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) agrees to an additional $4millon (in the region of £3.2million) funding to extend the Blue Sky collaboration with AstraZeneca beyond 2022.
Medical Research Council announces plans to halve carbon footprint by 2030
MRC announces its environmental sustainability programme to achieve net zero by 2040, as part of the UKRI sustainability strategy, with a 50% reduction by 2030.
Researchers will collaborate to create 11 new networks aimed at transforming UK ageing research
It is recognised that there is a need to improve research in this vital area. The Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) have therefore combined their investment power to the tune of £2 million to create the UK Ageing Networks.
Professor Sharon Peacock awarded the MRC Millennium Medal 2021
Professor Sharon Peacock, from the University of Cambridge and the COVID-19 Genomics UK (COG-UK) Consortium, has been awarded the MRC Millennium Medal 2021.
First detailed images captured of molecule associated with ALS
Scientists have determined the structure of the molecule associated with amyotrophic lateral sclerosis (ALS) and multiple other neurodegenerative diseases.
First cells reprogrammed to make synthetic polymers
Cells, using a synthetic genome, can make polymers from artificial building blocks for the first time, and the bacteria are also resistant to viral infections.
New data hub and research into chronic pain
The Medical Research Council (MRC) is leading a £16 million investment in research consortia and a data hub to advance chronic pain treatments.
Study finds shared origins for chronic diseases in multimorbidity
A study published in Nature Medicine identifies risk factors that increase the likelihood of individuals developing multiple non-communicable diseases.
National Mouse Genetics Network
The Medical Research Council (MRC) is investing more than £20m in a major new network in mouse genetics for disease modelling to accelerate our understanding of human disease and improve diagnosis and treatments.
MRC researchers receive Queen's Birthday Honours
Congratulations to Dr Jonathan Pearce, whose achievements were recognised in the Queen's Birthday Honours 2020, for services to Covid-19 Research.
New research to tackle Covid's impact on mental health receives £2 million boost
Six new projects worth a total of £2 million will give a much-needed boost in support for research investigating the impact of the COVID-19 pandemic on mental health.
UK and Japan award eight Regenerative Medicine projects
The Medical Research Council (MRC) and the Japan Agency for Medical Research and Development (AMED) have joined forces to support eight new Regenerative Medicine research partnerships. Four of these involve researchers from the University of Cambridge.
RECOVERY trial will evaluate REGN-COV2 investigational antibody cocktail in the UK
The University of Oxford and its partner Regeneron Pharmaceuticals, Inc have announced that RECOVERY (Randomised Evaluation of COVid-19 thERapY), one of the world’s largest randomised clinical trials of potential COVID-19 treatments, will evaluate Regeneron’s investigational anti-viral antibody cocktail, REGN-COV2.
£5 million for new research projects investigating how coronavirus spreads
Eight new projects will explore how the virus spreads in schoolchildren, healthcare workers, in medical settings, on surfaces in public spaces, and in strictly-Orthodox Jewish communities.
New molecule to repair and restore brain and spinal cord function
A molecule created by researchers can restore lost connections in the spinal cord and brain of mice with neurological disorders including cerebellar ataxia, Alzheimer’s disease and spinal cord injury. The research, involving scientists in the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge, and collaborators from Japan and Germany, describes how the molecule…
Unprecedented national effort by UK immunologists to search for answers on COVID-19
Three new UK-wide studies, bringing together scientists from 17 research institutions, will receive £8.4 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR) to understand immune responses to the novel coronavirus.
Nominations for the MRC Millennium Medal 2020 are now open
The Medical Research Council (MRC) has announced the launch of the Millennium Medal 2020, the MRC’s most prestigious award that is presented annually to an exceptional researcher who has made a major contribution towards the MRC’s mission to improve health, quality of life and wealth creation.
Largest ever study using wearable devices finds physical activity is beneficial for health, and more intense activity is better
Physical activity of any intensity is beneficial for health, but more intense activity has greater benefits, according to a new study.
Innovation Scholars: Data science training in health & bioscience
Funding is available for up to two years to enable the delivery of innovative training programmes to upskill health & bioscience researchers in data management and analysis.
MRC launches Experimental Medicine Panel
MRC is pleased to announce a new Experimental Medicine Panel, which will meet regularly to enhance the MRC’s current translational offering.
UKRI COVID-19 and ethnicity research
Understanding the reasons for vulnerability to COVID-19 and the differential social, cultural and economic impacts of the pandemic on minority ethnic groups: building on the UKRI previous call for research on COVID and ethnicity, UKRI is issuing a new call for proposals in this area to tackle the gaps in the research landscape.
Mapping the COVID-19 research landscape: How tracking medical research funding has accelerated in the pandemic
MRC Director of Strategic Evaluation and Impact, Dr Ian Viney MBE, highlights how the tracking of research projects has accelerated and become more globally-connected in the pandemic, to better support the rapid pace of worldwide discovery and clinical research.